Logotype for Oddity Tech Ltd

Oddity Tech (ODD) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Oddity Tech Ltd

Q3 2026 earnings summary

11 Nov, 2026

Executive summary

  • Q3 net revenue declined 2% YoY to $145.0M, and adjusted EBITDA was $22.0M; both exceeded guidance as revenue pressure eased from H1.

  • FY 2026 revenue and adjusted EBITDA outlooks were raised; 2027 priorities include returning brands to growth through launches, category expansion, technology, and ODDITY Labs.

  • SpoiledChild and METHODIQ advanced, while resolving IL MAKIAGE’s advertising-account dislocation remains key to its planned return to growth.

Financial highlights

  • Q3 net revenue was $145.0M versus $147.9M a year earlier; adjusted EBITDA was $22.0M versus $28.9M, above the $18M–$20M outlook.

  • 9M net revenue declined 20% YoY to $523.4M; adjusted EBITDA fell 82% to $27.9M.

  • Q3 net income was $11.2M versus $17.7M; 9M net income was $2.7M versus $104.9M.

  • Q3 free cash flow was $10M; 9M free cash flow was $2.5M, with operating cash flow of $4.9M and capex of $2.4M.

  • More than 80% of Q3 net revenue came from repeat sales; first-order net revenue declined by high teens YoY.

Outlook and guidance

  • FY 2026 net revenue is expected to decline 18.5%, versus prior guidance for a 19.0% decline; adjusted EBITDA guidance rose to $32M–$34M from $30M–$32M.

  • Q4 2026 net revenue is expected to decline 10%–11% YoY, with adjusted EBITDA of $4M–$6M.

  • 2027 goal is to return all brands, including IL MAKIAGE, to growth; Brand Four is planned for launch, alongside product launches across existing brands.

  • 2027 launches include ~8 SpoiledChild products and 5–6 IL MAKIAGE products; METHODIQ plans category expansion and prescription injectable and peptide therapies.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Oddity Tech